The 34th Annual Congress of the European Association of Nuclear Medicine (EANM) will be held virtually this year from October 20-23.
We are happy to inform you that our abstract entitled ‘Visual assessment and Centiloid quantification across diagnostic groups: the AMYPAD project’ has been accepted for an oral presentation within a Featured Session for the Scientific Programme of EANM'21.
Session: 911 - Featured Session: Molecular Imaging of Alzheimer's Disease
Information on the conference can be found here.
The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting with key leaders in Alzheimer's disease research getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.
This year the 14th annual CTAD conference will be on November 9-12, 2021 and will combine an onsite meeting in Boston with on-demand scientific content on a digital platform.
We are pleased that the AMYPAD abstract entitled "Current Status and Quantitative Results of the AMYPAD Prognostic and Natural History Study" has been accepted as an oral communication and will be presented on Thursday, November 11th at 2:50pm ET or 9:50pm CET (OC25).
Information on conference registrations can be found HERE.